Fact CheckerSign in

NCT06436131Completed

The Effects of In-phase Bilateral Exercise in People with Progressive Multiple Sclerosis

The Effects of In-phase Bilateral Exercise on Cognitive and Motor Outcome Measures, in Patients with Progressive Multiple Sclerosis, a Randomized Control Trial.

Source: ClinicalTrials.gov · Last updated 19 Sept 2024

Brief summary (registry, in English)

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. MS, typical presents with progression of clinical symptoms which mainly include motor and cognitive impairment, as well as reduction of patients' quality of life. Exercise is an effective approach in the management of the symptoms in people with progressive MS. Previous studies in healthy and in people with MS, reported a close relationship between cognitive functions and upper limb performance. Since patients with progressive MS facing difficulties with performing complex exercises due to cognitive dysfunctions and given the close relationship between cognitive functions and manual dexterity, a reasonable question arises whether a type of upper limbs exercises with less cognitive demands will improve the information processing speed in people with progressive MS. The aim of the current study is to investigate the effects of in-phase bilateral upper limbs exercises on the information processing speed, in patients with progressive MS, given that in-phase bilateral movements needs less attentional load than the other types of bilateral coordination. The intervention protocol lasted for 12 consecutive weeks (30-60 minutes /session x 3 sessions/week) and included in-phase bilateral exercises of the upper limbs, adapted to different sports activities and to functional training. Results from the statistical analysis indicated improvement of the experimental group compared to the control group, on the information processing speed alongside with improvement of motor skills.

Status (registry)
Completed
Study type
Interventional
Enrollment
20 (actual)
First submitted
19 Mar 2024
Start date
2 Oct 2023
Primary completion date
22 Dec 2023
Lead sponsor
Cyprus University of Technology
NCT number
NCT06436131

What you commit to

  • Study type: Interventional
  • Participants enrolled: 20
  • From 2 Oct 2023 to the primary completion date, 22 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • history of any disease affecting the central nervous system other than MS (e.g., stroke, Parkinson's disease, cerebral palsy)
  • history of cardiovascular disease (e.g., known aneurism, myocardial infarction, hyper/hypotension, heart failure)
  • severe orthopaedic disorders (e.g., knee or hip replacement, spondylosurgery, disk herniation, recent bone fracture)
  • mental disorders (e.g., depression, schizophrenia, bipolar syndrome)
  • history of epileptic seizures

Other

  • pregnancy during the implementation of the study timeline
  • hearing impairments (i.e., deafness)
  • visual deficit (e.g., optic neuritis, blindness, diplopia, glaucoma, blurred vision)
  • spasticity level on upper or lower limbs more than 1+ (slight increase in muscle tone) according to Modified Ashworth Scale

Who the study is looking for

  • diagnosis of progressive multiple sclerosis (MS) (primary or/and secondary progressive MS)
  • Expanded Disability Status Scale score between three and six
  • no relapse within 30 days
  • aged between 30 and 70 years
  • Mini Mental State of Examination score between 20 and 30 (mild to no cognitive impairment)

Age in the registry: 30 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dimitris Sokratous
Coordinator of this site? Confirm its status
LimassolCyprusUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.